ResolvedTier 3 — Critical

CYCLOPHOSPHAMIDE FOR INJECTION USP

ANDONE PHARMACEUTICAL INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of CYCLOPHOSPHAMIDE FOR INJECTION USP in Canada?

Not currently. The most recent shortage report for CYCLOPHOSPHAMIDE FOR INJECTION USP 1000MG is marked resolved (last updated September 16, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength1000MG

Last updated2026-09-16

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02546736

Strength

1000MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

CYCLOPHOSPHAMIDE

Tier

Tier 3 — Critical

Last Updated

2026-09-16

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from ANDONE PHARMACEUTICAL INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

CYCLOPHOSPHAMIDE FOR INJECTION USP

2000MG · DIN 02546744